FDA Safety Communication: use caution with implanted pumps for intrathecal administration of medicines for pain management. | PSNet

Provide Feedback |

Register

Press Release/Announcement

FDA Safety Communication: use caution with implanted pumps for intrathecal administration of medicines for pain management.

November 28, 2018

MedWatch Safety Alert. Silver Spring, MD: US Food and Drug Administration; November 14, 2018.

This safety announcement raises awareness of pump failures, dosing errors, and other potential safety issues associated with implanted pumps. Recommendations to enhance safety include review of medication labeling to select appropriate medicines and concentrations as well as open discussions with patients about risks associated with pump and medication options.

Related Resources From the Same Author(s)

FDA Safety Communication: recommendations to reduce surgical fires and related patient injury.

June 20, 2018

FDA Drug Safety Communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older.

February 7, 2018

ReliOn insulin syringes for use with U-100 insulin (Tyco Healthcare-Covidien).

May 24, 2015

FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration.

April 8, 2020

Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip).

June 22, 2011

Wear face masks with no metal during MRI exams.

December 16, 2020

Golden State Medical Supply, Inc. Issues a Voluntary Nationwide Recall of Atenolol 25 mg Tablets and Clopidogrel 75 mg Tablets Due to a Label Mix-up.

October 19, 2022

Hospira issues a voluntary nationwide recall for one lot of 0.5% Bupivacaine Hydrochloride Injection, USP and one lot of 1% Lidocaine HCl Injection, USP due to mislabeling.

May 19, 2021

Apotex Corp. issues voluntary nationwide recall of Enoxaparin Sodium Injection, USP due to mislabeling of syringe barrel measurement markings.

February 17, 2021

Meitheal Pharmaceuticals, Inc. issues voluntary nationwide recall of Cisatracurium Besylate Injection, USP 10mg per 5mL due to mislabeling.

February 10, 2021

View More

Related Resources

Annual Perspective

Equity in Patient Safety

March 27, 2024

Potential for medication overdose with ENFit low dose tip syringe: FDA Safety Communication.

October 20, 2021

Letter to Health Care Providers: Safe Use of Surgical Staplers and Staples.

October 7, 2021

FDA Safety Communication: update--robotically-assisted surgical devices in mastectomy.

August 20, 2021

FDA advises health care professionals and patients about insulin pen packaging and dispensing.

October 28, 2020

FDA alerts patients and health care professionals of EpiPen auto-injector errors related to device malfunctions and user administration.

April 8, 2020

FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering.

April 17, 2019

Infections associated with reprocessed flexible bronchoscopes.

September 30, 2015

Important change to heparin container labels to clearly state the total drug strength.

December 19, 2012

Maalox Total Relief and Maalox Liquid Products: Medication Use Errors.

March 3, 2010

View More

See More About The Topic

Health Care Providers

Family Members and Caregivers

To sign up for updates or to access your subscriber preferences, please enter your email address below.

5600 Fishers Lane
Rockville, MD 20857
Telephone: (301) 427-1364